Cited by 138Diabetes Management and ResearchDementia and Cognitive Impairment ResearchDiabetes Treatment and Management

Cognitive performance declines in older adults with type 1 diabetes: results from 32 years of follow-up in the DCCT and EDIC Study

Open access
Jacobson, Alan M, Ryan, Christopher M, Braffett, Barbara H, Gubitosi-Klug, Rose A, Lorenzi, Gayle M, Luchsinger, José A, Trapani, Victoria R, Bebu, Ionut +4 more·2021·The Lancet Diabetes & Endocrinology

Abstract

Background With improved treatment, individuals with type 1 diabetes are living longer but there is limited information on the effects of type 1 diabetes on cognitive ability as they become older adults. We followed up individuals with type 1 diabetes to identify independent risk factors for cognitive decline as people age.Methods 1051 participants with type 1 diabetes enrolled in the Diabetes Control and Complications Trial (DCCT) and its follow-up Epidemiology of Diabetes Interventions and Complications (EDIC) study. Participants completed cognitive assessments at baseline (median age 27 years) and 2, 5, 18, and 32 years later (median age 59). HbA 1c levels, frequency of severe hypoglycaemia, non-glycemic risk factors such as elevated blood pressure, and microvascular and macrovascular complications were assessed repeatedly. We examined the effects of these on measures of memory and psychomotor and mental efficiency. These studies are registered with clinicaltrials.gov, NCT00360815 (DCCT) and NCT00360893 (EDIC).Findings Over 32 years of follow-up, we found substantive declines in memory and psychomotor and mental efficiency. Between 18 and 32 years of follow-up, the decline in psychomotor and mental efficiency was five times larger than the change from baseline to year 18. Independent of the other risk factors and comorbidities, exposure to higher HbA 1c levels, more episodes of severe hypoglycaemia, and elevated systolic blood pressure were associated with greater decrements in psychomotor and mental efficiency that was most notable by year 32 (p<0·0001). The combined effect of the presence of these three risk factors is the equivalent to an additional 9·4 years of age.Interpretation Cognitive function declines with ageing in type 1 diabetes. The association of glycaemia and blood pressure levels with cognitive decline suggests that better management might preserve cognitive function.Funding United States National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(21)00086-3

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cognitive impairment has a strong bidirectional association with hypoglycemia.

    “Cognitive impairment has a strong bidirectional association with hypoglycemia, and recurrent severe hypoglycemic episodes were associated with a greater decline in psychomotor and mental efficiency after long-term follow-up of the DCCT/EDIC cohort (118).”

    From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [118]

    The Results report that severe hypoglycemia was associated with greater decline in psychomotor and mental efficiency over follow-up, with worsening performance as the number of events increased. The Results and Discussion address hypoglycemia followed by cognitive decline, but do not establish the reverse association—that cognitive impairment is associated with subsequent hypoglycemia—so they do not support the claim of bidirectionality. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Severe hypoglycemia has been linked to increased risk of dementia.

    “Cognitive decline has been associated with increased risk of hypoglycemia, and conversely, severe hypoglycemia has been linked to increased risk of dementia (30)(31)(32).”

    From 13. Older Adults: <i>Standards of Care in Diabetes—2024</i> (2024) · cites this paper as [32]

    The Results report that severe hypoglycemia was associated with declining psychomotor and mental efficiency in adults with type 1 diabetes, and the Discussion links it to clinically significant cognitive impairment. The paper does not report an increased risk of dementia, which is the more specific outcome in the claim. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Severe hypoglycemia has been linked to increased risk of dementia.

    “Cognitive decline has been associated with increased risk of hypoglycemia, and conversely, severe hypoglycemia has been linked to increased risk of dementia (37–39).”

    From 13. Older Adults: Standards of Care in Diabetes—2026 (2026) · cites this paper as [39]

    The Results and Discussion (page not provided) link severe hypoglycemia to declining psychomotor and mental efficiency and to clinically significant cognitive impairment in older adults with type 1 diabetes. They do not establish an increased risk of dementia, which is the more specific outcome in the claim. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Cognitive decline has been associated with increased risk of hypoglycemia.

    “Cognitive decline has been associated with increased risk of hypoglycemia, and conversely, severe hypoglycemia has been linked to increased risk of dementia (37–39).”

    From 13. Older Adults: Standards of Care in Diabetes—2026 (2026) · cites this paper as [39]

    The Results (page not available) associate a history of severe hypoglycemia with subsequent decline in psychomotor and mental efficiency. That supports an association between hypoglycemia and cognitive decline, but not the claimed direction: the paper does not show that cognitive decline is associated with an increased risk of future hypoglycemia. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Older adults with type 1 diabetes are more prone to mild cognitive impairment associated with hypoglycemia, while hypoglycemia occurs more frequently in those with cognitive impairment.

    “It appears that older adults with type 1 diabetes are more prone to mild cognitive impairment associated with hypoglycemia (110,111), while hypoglycemia occurs more frequently in those with cognitive impairment.”

    From The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2021) · cites this paper as [110]

    The Discussion (page unavailable) associates severe hypoglycemia with cognitive decline in older adults with type 1 diabetes and reports an increased risk of clinically significant impairment in related studies. It does not establish that this cohort was more prone to mild cognitive impairment: its reported rate of possible mild cognitive impairment was 5.5%, versus 6.7% in general-population studies. The citation appears immediately after the first clause, so the subsequent statement about hypoglycemia occurring more frequently in people with cognitive impairment is not judged here. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 36 · Cited by 138

Authors
Jacobson, A. M., Ryan, C. M., Braffett, B. H., Gubitosi-Klug, R. A., Lorenzi, G. M., Luchsinger, J. A., Trapani, V. R., Bebu, I., Chaytor, N., Hitt, S. M., Farrell, K., & Lachin, J. M.
Affiliations
  • NYU Langone Health (US)
  • University of Pittsburgh (US)
  • George Washington University (US)
  • University of California San Diego (US)
  • Washington State University Spokane (US)
  • University of Missouri (US)
  • Rainbow Babies & Children's Hospital (US)
Corresponding author
Jacobson, Alan M
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2021-07
Volume
9
Issue
7
Pages
436-445
ISSN
2213-8587 (ISSN-L)
OpenAlex
W3164205577
Cited by
138
References
36
Citations by year
2026: 25 · 2025: 36 · 2024: 23 · 2023: 24 · 2022: 22 · 2021: 8
FWCI
14.37
Type
journal article
Language
en
Open access
Locations
  • The Lancet Diabetes & Endocrinology (acceptedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Eli Lilly and Company
  • Abbott Diabetes Care
  • Insulet Corporation
  • National Eye Institute
  • BD
  • Roche Diabetes Care
  • National Institute of Neurological Disorders and Stroke (2006)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK094157, U01 DK094176)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
type 1 diabetes, cognitive decline, older adults, memory, psychomotor efficiency, mental efficiency, HbA1c, glycemic control, severe hypoglycemia, systolic blood pressure, diabetes complications, aging, Diabetes Control and Complications Trial
MeSH terms
Adolescent, Adult, Aged, Cognition, Diabetes Mellitus, Type 1, Female, Follow-Up Studies, Humans, Male, Middle Aged, Time Factors, Young Adult, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review